comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 15:29:53 - browse：5688

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Oral obesity drug from Viking Therapeutics hits key early target

leisure time

WSS

Supreme Court mifepristone arguments center on docs' right to sue

Mass General Brigham physicians react to latest merger step

Abortion pill case raises question: who can sue the FDA?

Washington mulls new rules to avert another Change Healthcare

U.K. decision on ALS drug has neurologists, advocates up in arms

Study: Black kids more likely to die after surgery than white kids

explore

comprehensive

focus

23andMe had bad news about my health. I wish a person had delivered it

Oprah kicked off a national conversation on obesity. Let's have it

Medicare proposal to cover medical devices draws a mixed reaction

Scientific mystery highlights the blind spots in genomics databases

Alkermes shareholders re

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Supreme Court strikes down use of affirmative action

People with mental disorders often marry others with same

Jerome Adams on the need for new antivirals for Covid

Primary care physicians play key roles in Alzheimer's management

hotspot

Primary care physicians play key roles in Alzheimer's management

People with mental disorders often marry others with same

Oral obesity drug from Viking Therapeutics hits key early target

Primary care physicians play key roles in Alzheimer's management

Young boy dies in trial for Pfizer Duchenne gene therapy

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

hotspot

leisure time

knowledge